These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6252159)

  • 21. [Sulbenicillin].
    Gava R
    G Clin Med; 1988 Dec; 69(12):789-92. PubMed ID: 3149598
    [No Abstract]   [Full Text] [Related]  

  • 22. [Penetration of antimicrobial agents into broncho-alveolar lavage fluids--a comparative study of cefotiam and sulbenicillin].
    Kato M; Hattori M; Tuzuki M; Kato J; Hayashi Y; Yoshitomo K; Tashiro T; Nanjo K; Usami I; Kuroki H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Aug; 23(8):888-94. PubMed ID: 3866100
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cefminox versus cefotaxime in the treatment of complicated urinary tract infection].
    Gastón de Iriarte E; Cárcamo Valor P; Diez-Enciso M; Prieto Prieto J; Pérez Balcabao I; Gimeno del Sol M; Coronel Granado P; Morán Soto MJ
    Actas Urol Esp; 1995 Sep; 19(8):635-41. PubMed ID: 8669331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefoperazone for the treatment of acute urinary tract infection: multicentered comparative and noncomparative studies.
    File TM; Tan JS
    Rev Infect Dis; 1983; 5 Suppl 1():S145-53. PubMed ID: 6221384
    [No Abstract]   [Full Text] [Related]  

  • 25. Cefotaxime in urinary tract infections--comparative clinical studies with gentamicin and with cefoxitin.
    Ludwig G; Knebel L
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():207-11. PubMed ID: 6252158
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical trials of flomoxef in complicated urinary tract infections].
    Ohta N; Sudoko H; Fukuta K; Nakano M; Ushiyama T; Tajima A; Aso Y; Masuda H; Suzuki A; Suzuki K
    Jpn J Antibiot; 1987 Oct; 40(10):1835-44. PubMed ID: 3444025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cephacetrile, a new cephalosporin, in the treatment of urinary tract infections.
    Wise R; Reeves DS; Hepburn PR
    Chemotherapy; 1974; 20(3):177-82. PubMed ID: 4211859
    [No Abstract]   [Full Text] [Related]  

  • 28. [An autopsy case of fatal anaphylactic shock following intra-venous administration of sulbenicillin].
    Fukui Y; Takahashi S; Matsubara K; Kimura K; Nonomura K; Nakahara M
    Nihon Hoigaku Zasshi; 1983 Apr; 37(2):121-4. PubMed ID: 6674633
    [No Abstract]   [Full Text] [Related]  

  • 29. Cefotaxime for urinary tract infections.
    Newsom SW; Matthews J; Pearce VR
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():199-203. PubMed ID: 6252157
    [No Abstract]   [Full Text] [Related]  

  • 30. [Evaluation of clinical efficacy of sulbenicillin following surgery of malignant maxillary tumors. Transport of sulbenicillin to the exudates from the surgical wound of the maxilla and its therapeutic effects].
    Hakamata M; Hozawa J; Saito H; Fukuoka K; Yamagami M; Usami S
    Jpn J Antibiot; 1982 May; 35(5):1254-60. PubMed ID: 7131758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cost-effectiveness comparative study of ceftriaxone verus cefotaxime in the treatment of complicated urinary infections].
    Martínez Jabaloyas JM; Sanz Chinesta S; Jiménez Cruz JF; Flores Corral N; Unda Urzaiz M; Leiva Galvis O; González Romojaro V; Hernández Fernández C; Lledó García E; Rioja Sanz LA; Gonzalvo Ibarra A; Camacho González JE; Ruíz Alvárez-Cienfuegos F; Resel Estévez L; Corral Saleta J; Burgos Rodríguez R; Del Rosal Samaniego JM
    Actas Urol Esp; 1997; 21(7):668-74. PubMed ID: 9412209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of complicated urinary tract infection with cefoperazon].
    Rothenberger K; Hofstetter A; Friesen A
    Fortschr Med; 1981 Jan; 99(1-2):39-41. PubMed ID: 6451568
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical evaluation of cephalexin in the treatment of urinary tract infections.
    Eyckmans L
    Chemotherapy; 1970; 15(5):322-30. PubMed ID: 5495425
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical experience of cefotaxime (author's transl)].
    Portier H; Carbon C; Boussougant Y; Destaing F
    Nouv Presse Med; 1981 Feb; 10(8):607-11. PubMed ID: 6259603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lymphocyte proliferation test of experimental sulbenicillin rash].
    Aihara M; Kitamura K; Ikezawa Z; Nagai R
    Nihon Hifuka Gakkai Zasshi; 1985 May; 95(6):637-41. PubMed ID: 3162054
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical experience with the fourth generation cephalosporins.
    Giamarellou H
    J Chemother; 1996 Feb; 8 Suppl 2():91-104. PubMed ID: 8738851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ceftizoxime therapy of infections in hospitalized patients and comparison with cefamandole for urinary tract infections.
    Cohen E; Mogabgab WJ
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():253-60. PubMed ID: 6296017
    [No Abstract]   [Full Text] [Related]  

  • 38. [The use of cefotaxime against infections (author's transl)].
    Lepeu G; Bertrand A; Armengaud M; Aubertin J
    Nouv Presse Med; 1981 Feb; 10(8):594-7. PubMed ID: 6259600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the minimal bactericidal time (MBT) of sulbenicillin against multiresistant pathogens.
    Debbia E; Pesce A; Schito GC
    Chemioterapia; 1987 Apr; 6(2):85-7. PubMed ID: 3647850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical evaluation of cefotaxime at various dosage levels in urinary tract infections (author's transl)].
    Guibert J; Acar JF; Justin C; Kitzis MD
    Nouv Presse Med; 1981 Feb; 10(8):625-7. PubMed ID: 6259607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.